Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Identification and Integration of Multi-omic Biomarkers for the Characterization of Patients With Developmental and Epileptic Encephalopathies (DEE) With a View to Clinical Trials / Identificazione e Integrazione di Multi-omici Biomarcatori Per la Caratterizzazione Dei Pazienti Con Encefalopatie Epilettiche e Dello Sviluppo (DEE) in Vista Dei Trials Clinici
Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS): a Multicentre Study of the PRES Scleroderma Working Party in Collaboration With Members of the CARRA Scleroderma Working Group
Understanding the Subnormal Rescue ofNeurological Development in Congenital Hypothyroidism (Comprendere le Ragioni Dell'Incompleta Correzione Dei Difetti Dello Sviluppo Neurologico Nell'Ipotiroidismo Congenito)
Bone Health in Adult Patients With Duchenne Muscular Dystrophy: A Survey on Osteoporosis, Fractures, and Their Treatment.
Combining Gene Editing and iPS to Study and Treat Monogenic Autoinflammatory Diseases
Development of a Cloud Platform for Advanced Diagnostics Based on Clinical and Omics Data - Sviluppo di Una Piattaforma Cloud Per la Diagnostica Avanzata Basata su Dati Clinico-omici
Un Approccio di Medicina di Precisione Per Valutare la Perdita di Funzione Proteica e il Potenziale Recupero di CFTR in Fibrosi Cistica e Patologie Correlate / A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)